BIOMAT Database Logo BIOMAT Database Logo

A comparison of prostate cancer survival in England, Norway and Sweden: a population-based study. 2012

L Holmberg, and D Robinson, and F Sandin, and F Bray, and K M Linklater, and A Klint, and P C Lambert, and J Adolfsson, and F C Hamdy, and J Catto, and H Møller
King's College London, Medical School, Division of Cancer Studies, Section of Cancer Epidemiology, SE1 9RT London, UK. lars.holmberg@kcl.ac.uk

OBJECTIVE The objective of the study was to compare patterns of survival 2001-2004 in prostate cancer patients from England, Norway and Sweden in relation to age and period of follow-up. METHODS Excess mortality in men with prostate cancer was estimated using nation-wide cancer register data using a period approach for relative survival. 179,112 men in England, 23,192 in Norway and 59,697 in Sweden were included. RESULTS In all age groups, England had the lowest survival, particularly so among men aged 80+. Overall age-standardised five-year survival was 76.4%, 80.3% and 83.0% for England, Norway and Sweden, respectively. The majority of the excess deaths in England were confined to the first year of follow-up. CONCLUSIONS The results indicate that a small but important group of older patients present at a late stage and succumb early to their cancers, possibly in combination with severe comorbidity, and this situation is more common in England than in Norway or Sweden.

UI MeSH Term Description Entries
D008297 Male Males
D008403 Mass Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease. Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D009664 Norway A country located in northern Europe, bordering the North Sea and the Atlantic Ocean, west of Sweden. The capital is Oslo. Kingdom of Norway
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D004739 England A part of Great Britain within the United Kingdom.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D013548 Sweden Country in northern Europe, bordering the Baltic Sea, between Finland and Norway. The capital is Stockholm.
D015980 Public Health Practice The activities and endeavors of the public health services in a community on any level. Health Practice, Public,Health Practices, Public,Practice, Public Health,Practices, Public Health,Public Health Practices

Related Publications

L Holmberg, and D Robinson, and F Sandin, and F Bray, and K M Linklater, and A Klint, and P C Lambert, and J Adolfsson, and F C Hamdy, and J Catto, and H Møller
Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study.
January 2019, The Lancet. Oncology,
L Holmberg, and D Robinson, and F Sandin, and F Bray, and K M Linklater, and A Klint, and P C Lambert, and J Adolfsson, and F C Hamdy, and J Catto, and H Møller
Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden.
February 1997, JAMA,
L Holmberg, and D Robinson, and F Sandin, and F Bray, and K M Linklater, and A Klint, and P C Lambert, and J Adolfsson, and F C Hamdy, and J Catto, and H Møller
Survival in patients diagnosed with castration-resistant prostate cancer: a population-based observational study in Sweden.
April 2020, Scandinavian journal of urology,
L Holmberg, and D Robinson, and F Sandin, and F Bray, and K M Linklater, and A Klint, and P C Lambert, and J Adolfsson, and F C Hamdy, and J Catto, and H Møller
Metformin use and lung cancer survival: a population-based study in Norway.
March 2021, British journal of cancer,
L Holmberg, and D Robinson, and F Sandin, and F Bray, and K M Linklater, and A Klint, and P C Lambert, and J Adolfsson, and F C Hamdy, and J Catto, and H Møller
Survival outcomes in myelofibrosis patients treated with ruxolitinib: A population-based cohort study in Sweden and Norway.
December 2019, European journal of haematology,
L Holmberg, and D Robinson, and F Sandin, and F Bray, and K M Linklater, and A Klint, and P C Lambert, and J Adolfsson, and F C Hamdy, and J Catto, and H Møller
Predictors of ovarian cancer survival: a population-based prospective study in Sweden.
August 2008, International journal of cancer,
L Holmberg, and D Robinson, and F Sandin, and F Bray, and K M Linklater, and A Klint, and P C Lambert, and J Adolfsson, and F C Hamdy, and J Catto, and H Møller
Radiotherapy and survival in prostate cancer patients: a population-based study.
January 2009, International journal of radiation oncology, biology, physics,
L Holmberg, and D Robinson, and F Sandin, and F Bray, and K M Linklater, and A Klint, and P C Lambert, and J Adolfsson, and F C Hamdy, and J Catto, and H Møller
Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study.
March 2013, British journal of cancer,
L Holmberg, and D Robinson, and F Sandin, and F Bray, and K M Linklater, and A Klint, and P C Lambert, and J Adolfsson, and F C Hamdy, and J Catto, and H Møller
Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004-2007.
June 2013, Thorax,
L Holmberg, and D Robinson, and F Sandin, and F Bray, and K M Linklater, and A Klint, and P C Lambert, and J Adolfsson, and F C Hamdy, and J Catto, and H Møller
Familial and hereditary prostate cancer in southern Sweden. A population-based case-control study.
February 1999, European journal of cancer (Oxford, England : 1990),
Copied contents to your clipboard!